Please enable JavaScript to continue using this application.

Compare $IMDX vs $IMUX | Chartloom

Compare

$IMDX vs $IMUX

Insight Molecular Diagnostics Inc · Immunic Inc

IMDX

Insight Molecular Diagnostics Inc

IMUX

Immunic Inc

Compare $IMDX vs $IMUX

Comparing Insight Molecular Diagnostics Inc and Immunic Inc

IMDXInsight Molecular Diagnostics Inc

IMUXImmunic Inc

IMDXInsight Molecular Diagnostics Inc

Market cap

$109M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

58.81x

Rev growth (TTM)

-60.8%

YTD performance

-52.9%

52W performance

-8.4%

FCF yield

-28.4%

IMUXImmunic Inc

Market cap

$112M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

40.5%

52W performance

-8.8%

FCF yield

-78.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IMDX

IMUX

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

IMUX

Immunic Inc

Market Cap

IMDX$109M

IMUX$112M

Enterprise Value

IMDX$92M

IMUX$-44M

Price

IMDX$3.37

IMUX$8.19

P/E Ratio

IMDXN/A

IMUXN/A

P/S Ratio

IMDX65.16x

IMUX0.00x

EV/Sales

IMDX54.99x

IMUX0.00x

EV/EBITDA

IMDX0.00x

IMUX0.00x

P/B Ratio

IMDX102.52x

IMUX0.85x

P/FCF Ratio

IMDXN/A

IMUXN/A

EV/FCF

IMDX-2.97x

IMUX0.49x

PEG Ratio

IMDXN/A

IMUXN/A

Forward P/E (NTM)

IMDXN/A

IMUXN/A

Forward P/S (NTM)

IMDX58.81x

IMUXN/A

Revenue (TTM)

IMDX$2M

IMUX$0

Revenue Growth (YoY)

IMDX-60.8%

IMUXN/A

Forward Rev Growth

IMDX593.7%

IMUX650.4%

Gross Margin (TTM)

IMDX48.3%

IMUX0.0%

Operating Margin (TTM)

IMDX0.0%

IMUX0.0%

EBITDA Margin (TTM)

IMDX-1986.2%

IMUX0.0%

Net Margin (TTM)

IMDX-2955.6%

IMUX0.0%

FCF Margin (TTM)

IMDX-1848.8%

IMUXN/A

Net Income (TTM)

IMDX$-49M

IMUX$-112M

FCF (TTM)

IMDX$-31M

IMUX$-88M

EPS (TTM)

IMDX-$1.34

IMUX-$2.62

ROE (TTM)

IMDX-42668.0%

IMUX-9567.0%

ROA (TTM)

IMDX-14147.0%

IMUX-10788.0%

ROIC (TTM)

IMDX-37415.0%

IMUX-9567.0%

Cash

IMDX$18M

IMUX$155M

Debt

IMDX$766K

IMUX$0

Net Cash/Debt

IMDX$17M

IMUX$155M

Current Ratio (TTM)

IMDX2.00x

IMUX5.05x

Quick Ratio (TTM)

IMDX1.82x

IMUX5.00x

Debt/Equity (TTM)

IMDX0.92x

IMUX0.00x

Debt/Assets (TTM)

IMDX0.0%

IMUX0.0%

Interest Coverage (TTM)

IMDXN/A

IMUXN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

IMUX0.00x

Beta

IMDX1.86

IMUX1.47

52W Performance

IMDX-8.4%

IMUX-8.8%

YTD Performance

IMDX-52.9%

IMUX40.5%

% from 52W High

IMDX-60.4%

IMUX-53.0%

% from 52W Low

IMDX39.3%

IMUX61.9%

Asset Turnover (TTM)

IMDX0.05x

IMUX0.00x

FCF Yield (TTM)

IMDX-28.4%

IMUX-78.9%

Earnings Yield (TTM)

IMDX-45.4%

IMUX-100.0%

Dividend Yield (TTM)

IMDXN/A

IMUXN/A

Rule of 40

IMDX-1,909.6

IMUX0.0

EV/GP/RG

IMDX10.54

IMUXN/A

Ticker research

View IMDX research View IMUX research

Metric	IMDX Insight Molecular Diagnostics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$109M	$112M
Enterprise Value	$92M	$-44M
Price	$3.37	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	65.16x	0.00x
EV/Sales	54.99x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	102.52x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.97x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-60.8%	N/A
Forward Rev Growth	593.7%	650.4%
Profitability
Gross Margin (TTM)	48.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1986.2%	0.0%
Net Margin (TTM)	-2955.6%	0.0%
FCF Margin (TTM)	-1848.8%	N/A
Net Income (TTM)	$-49M	$-112M
FCF (TTM)	$-31M	$-88M
EPS (TTM)	-$1.34	-$2.62
ROE (TTM)	-42668.0%	-9567.0%
ROA (TTM)	-14147.0%	-10788.0%
ROIC (TTM)	-37415.0%	-9567.0%
Financial Health
Cash	$18M	$155M
Debt	$766K	$0
Net Cash/Debt	$17M	$155M
Current Ratio (TTM)	2.00x	5.05x
Quick Ratio (TTM)	1.82x	5.00x
Debt/Equity (TTM)	0.92x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	1.47
52W Performance	-8.4%	-8.8%
YTD Performance	-52.9%	40.5%
% from 52W High	-60.4%	-53.0%
% from 52W Low	39.3%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.4%	-78.9%
Earnings Yield (TTM)	-45.4%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	0.0
EV/GP/RG	10.54	N/A
Ticker research	View IMDX research	View IMUX research

Valuation

P/S Ratio

IMUX

0.00x

IMDX

65.16x

EV/FCF

IMDX

-2.97x

IMUX

0.49x

Growth & revenue

Revenue Growth TTM

IMDX

-60.8%

Forward Revenue Growth

IMUX

650.4%

IMDX

593.7%

Profitability & performance

Gross Margin

IMDX

48.3%

IMUX

0.0%

ROE

IMUX

-9567.0%

IMDX

-42668.0%

FCF Yield %

IMDX

-28.4%

IMUX

-78.9%

52-Week Performance

IMDX

-8.4%

IMUX

-8.8%

Detailed metrics comparison

IMDX

Insight Molecular Diagnostics Inc

IMUX

Immunic Inc

Market Cap

IMDX$109M

IMUX$112M

Enterprise Value

IMDX$92M

IMUX$-44M

Price

IMDX$3.37

IMUX$8.19

P/E Ratio

IMDXN/A

IMUXN/A

P/S Ratio

IMDX65.16x

IMUX0.00x

EV/Sales

IMDX54.99x

IMUX0.00x

EV/EBITDA

IMDX0.00x

IMUX0.00x

P/B Ratio

IMDX102.52x

IMUX0.85x

P/FCF Ratio

IMDXN/A

IMUXN/A

EV/FCF

IMDX-2.97x

IMUX0.49x

PEG Ratio

IMDXN/A

IMUXN/A

Forward P/E (NTM)

IMDXN/A

IMUXN/A

Forward P/S (NTM)

IMDX58.81x

IMUXN/A

Revenue (TTM)

IMDX$2M

IMUX$0

Revenue Growth (YoY)

IMDX-60.8%

IMUXN/A

Forward Rev Growth

IMDX593.7%

IMUX650.4%

Gross Margin (TTM)

IMDX48.3%

IMUX0.0%

Operating Margin (TTM)

IMDX0.0%

IMUX0.0%

EBITDA Margin (TTM)

IMDX-1986.2%

IMUX0.0%

Net Margin (TTM)

IMDX-2955.6%

IMUX0.0%

FCF Margin (TTM)

IMDX-1848.8%

IMUXN/A

Net Income (TTM)

IMDX$-49M

IMUX$-112M

FCF (TTM)

IMDX$-31M

IMUX$-88M

EPS (TTM)

IMDX-$1.34

IMUX-$2.62

ROE (TTM)

IMDX-42668.0%

IMUX-9567.0%

ROA (TTM)

IMDX-14147.0%

IMUX-10788.0%

ROIC (TTM)

IMDX-37415.0%

IMUX-9567.0%

Cash

IMDX$18M

IMUX$155M

Debt

IMDX$766K

IMUX$0

Net Cash/Debt

IMDX$17M

IMUX$155M

Current Ratio (TTM)

IMDX2.00x

IMUX5.05x

Quick Ratio (TTM)

IMDX1.82x

IMUX5.00x

Debt/Equity (TTM)

IMDX0.92x

IMUX0.00x

Debt/Assets (TTM)

IMDX0.0%

IMUX0.0%

Interest Coverage (TTM)

IMDXN/A

IMUXN/A

Net Debt/EBITDA (TTM)

IMDX0.00x

IMUX0.00x

Beta

IMDX1.86

IMUX1.47

52W Performance

IMDX-8.4%

IMUX-8.8%

YTD Performance

IMDX-52.9%

IMUX40.5%

% from 52W High

IMDX-60.4%

IMUX-53.0%

% from 52W Low

IMDX39.3%

IMUX61.9%

Asset Turnover (TTM)

IMDX0.05x

IMUX0.00x

FCF Yield (TTM)

IMDX-28.4%

IMUX-78.9%

Earnings Yield (TTM)

IMDX-45.4%

IMUX-100.0%

Dividend Yield (TTM)

IMDXN/A

IMUXN/A

Rule of 40

IMDX-1,909.6

IMUX0.0

EV/GP/RG

IMDX10.54

IMUXN/A

Ticker research

View IMDX research View IMUX research

Metric	IMDX Insight Molecular Diagnostics Inc	IMUX Immunic Inc
Market & Valuation
Market Cap	$109M	$112M
Enterprise Value	$92M	$-44M
Price	$3.37	$8.19
P/E Ratio	N/A	N/A
P/S Ratio	65.16x	0.00x
EV/Sales	54.99x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	102.52x	0.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.97x	0.49x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	58.81x	N/A
Revenue & Growth
Revenue (TTM)	$2M	$0
Revenue Growth (YoY)	-60.8%	N/A
Forward Rev Growth	593.7%	650.4%
Profitability
Gross Margin (TTM)	48.3%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1986.2%	0.0%
Net Margin (TTM)	-2955.6%	0.0%
FCF Margin (TTM)	-1848.8%	N/A
Net Income (TTM)	$-49M	$-112M
FCF (TTM)	$-31M	$-88M
EPS (TTM)	-$1.34	-$2.62
ROE (TTM)	-42668.0%	-9567.0%
ROA (TTM)	-14147.0%	-10788.0%
ROIC (TTM)	-37415.0%	-9567.0%
Financial Health
Cash	$18M	$155M
Debt	$766K	$0
Net Cash/Debt	$17M	$155M
Current Ratio (TTM)	2.00x	5.05x
Quick Ratio (TTM)	1.82x	5.00x
Debt/Equity (TTM)	0.92x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.86	1.47
52W Performance	-8.4%	-8.8%
YTD Performance	-52.9%	40.5%
% from 52W High	-60.4%	-53.0%
% from 52W Low	39.3%	61.9%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	0.00x
FCF Yield (TTM)	-28.4%	-78.9%
Earnings Yield (TTM)	-45.4%	-100.0%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,909.6	0.0
EV/GP/RG	10.54	N/A
Ticker research	View IMDX research	View IMUX research